Visakhapatnam, Andhra Pradesh, India
GST : 37AQIPD1558N1ZI
Verified
Add Review
Our Products
COATS® (an acronym for Colloidal Oatmeal System) is a patented and unique nitrile glove technology. COATS® utilises the powerful benefits of all-natural oats, an FDA-recognised skin protectant, as a coating that forms a natural, moisturising barrier between the glove and skin. This acts as a preventative measure against skin irritation, and eliminates uncomfortable and irritating conditions experienced when wearing normal gloves. Users who suffer from dry and itchy skin due to frequent hand washing and glove usage can now rely on COATS® to soothe and nurture the skin, and protect their hands while they work.
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a COATS® nitrile glove at 21.9 minutes and 36.0 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
Additional Information:
Packaging Details : Configuration
200 gloves per box for XS to L
180 gloves per box for XL
10 boxes per carton
Reorder Code & Size
| REORDER CODE | SIZE |
|---|---|
| CTS38XS | X-Small |
| CTS38SS | Small |
| CTS38MM | Medium |
| CTS38LL | Large |
| CTS38XL | X-Large |
Physical Properties
| PHYSICAL PROPERTIES | BEFORE AGEING | AFTER AGEING |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
Inspection Levels And AQL
| INSPECTION LEVELS AND AQL | INSPECTION LEVEL | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4 |
| Tensile Strength | S2 | 4 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Colloidal Oatmeal Content | N=5 | ≥5mg/glove |
Details
| Chemotherapy Drugs and Concentration (tested for Resistance to Permeation By Chemotherapy Drugs as Per ASTM D6978-05, Test Report Pn 134889A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 21.9 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 36 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
To don Eureka is to experience absolute dexterity, comfort fitting and all the properties of a quality nitrile glove, everytime.
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Eureka nitrile glove at 7.3 minutes and 20.6 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
Additional Information:
Packaging Details : Configuration
300 gloves per box for XS to L
270 gloves per box for XL
10 boxes per carton
Reorder Code & Size
| REORDER CODE | SIZE |
|---|---|
| NTR61XS | X-Small |
| NTR61SS | Small |
| NTR61MM | Medium |
| NTR61LL | Large |
| NTR61XL | X-Large |
PHYSICAL PROPERTIES
| BEFORE AGEING | AFTER AGEING | |
|---|---|---|
| Tensile Strength (MPa) | ≥14 | ≥14 |
| Elongation (%) | ≥500 | ≥400 |
Inspection Levels And AQL
| INSPECTION LEVEL | AQL | |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4 |
| Tensile Strength | S2 | 4 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4 |
| Particulate Residue | N=5 | ≤2mg/glove |
Details
| Chemotherapy Drugs and Concentration (tested for Resistance to Permeation By Chemotherapy Drugs As per ASTM D6978-05, Test Report PN 128134A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 7.3 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 20.6 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
GloveOn Maverick LC is a worthy addition to the Maverick family. The all-rounder glove is thicker with an extended cuff length to suit situations which require greater protection.
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Maverick LC nitrile glove at 15.1 minutes and 30.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
Additional Information:
Packaging Details : 100 gloves per box for XS to XL
80 gloves per box for XXL
10 boxes per carton
Reorder Code & Size
| REORDER CODE | SIZE |
|---|---|
| NTR26XS | X-Small |
| NTR26SS | Small |
| NTR26MM | Medium |
| NTR26LL | Large |
| NTR26XL | X-Large |
| NTR26XXL | XX-Large |
Physical Properties
| BEFORE AGEING | AFTER AGEING | |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
Inspection Levels And AQL
| INSPECTION LEVEL | AQL | |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4 |
| Tensile Strength | S2 | 4 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4 |
| Particulate Residue | N=5 | ≤2mg/glove |
Details
| Chemotherapy Drugs and Concentration (tested for Resistance to Permeation By Chemotherapy Drugs As per ASTM D6978-05, Test Report PN 101567) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 15.1 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 30.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Eureka nitrile glove at 7.3 minutes and 20.6 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
GloveOn Hartson allows you to feel better protected to give you the confidence to perform the tasks at hand. With an extended cuff for superior coverage, high tensile strength and great chemical resistance backed by rigorous testing, Hartson provides exceptional levels of safety. Its formulation also caters for tasks needing first-rate dexterity thanks to its superb elongation which also delivers excellent comfort.
Regulations Compliance
International Standards
Manufacturing Accreditations
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Maverick LC nitrile glove at 15.1 minutes and 30.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.
Additional Information:
Packaging Details : Configuration
100 gloves per box for XS to XL
80 gloves per box for XXL
10 boxes per carton
Reorder Code & Size
| REORDER CODE | SIZE |
|---|---|
| HTS111XS | X-Small |
| HTS111SS | Small |
| HTS111MM | Medium |
| HTS111LL | Large |
| HTS111XL | X-Large |
| HTS111XXL | XX-Large |
Physical Properties
| BEFORE AGEING | AFTER AGEING | |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
Inspection Levels And AQL
| INSPECTION LEVEL | AQL | |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4 |
| Tensile Strength | S2 | 4 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4 |
| Particulate Residue | N=5 | ≤2mg/glove |
Details
| Chemotherapy Drugs and Concentration (tested for Resistance to Permeation By Chemotherapy Drugs As per ASTM D6978-05, Test Report Pn 101567) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 15.1 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 30.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
